Internal Medicine, Hematology & Oncology · Birmingham, AL
NPI
1588637250
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2728 10th Ave S Ste 200, Bruno Cancer Center
Birmingham, AL, 35205
Phone (205) 939-7880
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
219,476 services
Medicare patients, 2024
4,735
Average age 75
Drug cost, 2024
$7.8M
5,169 prescriptions
Company payments, 2025
$3,243
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cara C Bondly was code 80053 (clinical chemistry), 16,024 times for 4,486 patients. In total Cara C Bondly billed 219,476 services in 146 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80053 Clinical Chemistry | Office | 16,024 | 4,486 | $10.26 | $164K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 11,200 | 16 | $44.96 | $504K |
| J0897 Injection, denosumab, 1 mg | Office | 10,620 | 39 | $20.52 | $218K |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,354 | 13 | $0.08 | $658 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,650 | 11 | $0.11 | $861 |
| 82784 Immunoassay | Office | 6,494 | 929 | $9.06 | $59K |
| 82728 Clinical Chemistry | Office | 6,286 | 2,808 | $13.23 | $83K |
| 85025 Blood Count | Office | 6,094 | 1,613 | $7.56 | $46K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,100 | 38 | $15.36 | $78K |
| 83540 Clinical Chemistry | Office | 5,003 | 2,332 | $6.30 | $32K |
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,380 | 16 | $37.77 | $165K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,378 | 47 | $0.09 | $382 |
| 83615 Clinical Chemistry | Office | 4,130 | 1,442 | $5.90 | $24K |
| J1556 Injection, immune globulin (bivigam), 500 mg | Office | 2,970 | 16 | $58.16 | $173K |
| 82746 Clinical Chemistry | Office | 2,480 | 1,557 | $14.27 | $35K |
By year: 2022 $3.5M for 295,494 services; 2023 $2.6M for 194,668 services; 2024 $4.0M for 219,476 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 16,024 | 4,486 | $10.26 | $164K |
| 82784 Immunoassay | 6,494 | 929 | $9.06 | $59K |
| 82728 Clinical Chemistry | 6,286 | 2,808 | $13.23 | $83K |
| 85025 Blood Count | 6,094 | 1,613 | $7.56 | $46K |
| 83540 Clinical Chemistry | 5,003 | 2,332 | $6.30 | $32K |
| 83615 Clinical Chemistry | 4,130 | 1,442 | $5.90 | $24K |
| 82746 Clinical Chemistry | 2,480 | 1,557 | $14.27 | $35K |
| 82607 Clinical Chemistry | 2,023 | 1,453 | $14.64 | $30K |
| 86300 Immunoassay | 1,533 | 622 | $20.19 | $31K |
| 84443 Clinical Chemistry | 1,442 | 503 | $16.36 | $24K |
Medicare prescription drug claims, 2024
In 2024, the drug Cara C Bondly prescribed most often to Medicare patients was Letrozole, with 1,144 prescriptions and refills. In total Cara C Bondly wrote 5,169 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 1,144 | 2,102 | 225 | $21K |
| Exemestane Generic | 263 | 417 | 51 | $52K |
| Ondansetron Hcl Generic | 227 | 232 | 81 | $2,303 |
| Potassium Chloride Generic | 168 | 237 | 39 | $1,886 |
| Anastrozole Generic | 146 | 255 | 25 | $2,749 |
| Eliquis Apixaban | 130 | 170 | 25 | $96K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 121 | 243 | 31 | $1,986 |
| Pantoprazole Sodium Generic | 118 | 192 | 32 | $977 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 109 | 109 | 38 | $2,653 |
| Gabapentin Generic | 102 | 127 | 24 | $632 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 98 | 99 | 41 | $3,215 |
| Zolpidem Tartrate Generic | 88 | 90 | 19 | $407 |
| Omeprazole Generic | 81 | 138 | 18 | $1,201 |
| Ibandronate Sodium Generic | 81 | 210 | 28 | $2,742 |
| Valacyclovir Valacyclovir Hcl | 75 | 125 | 19 | $2,873 |
Brand drugs: 657 claims; generic drugs: 4,512 claims; opioid claims: 271.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cara C Bondly $3,243 ($3,243 in general payments such as food, travel and fees) from 40 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,118.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 22 | $1,118 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $210 |
| Abbvie Inc. ABBV | 11 | $152 |
| Celgene Corporation BMY | 6 | $126 |
| Daiichi Sankyo Inc. 4568.T | 5 | $117 |
| BeOne Medicines USA, Inc. ONC | 6 | $103 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $93.93 |
| Janssen Biotech, Inc. JNJ | 5 | $92.44 |
| Deciphera Pharmaceuticals Inc. | 3 | $89.53 |
| Merck Sharp & Dohme LLC MRK | 3 | $83.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.